Professor Jeffrey Shaw receives international recognition

The honor was given during the opening ceremony of the 66th Annual Meeting of the ASTMH

Nota Informativa – Vacina Dengue Dengvaxia®

A Dengvaxia® – vacina dengue 1, 2, 3 e 4 (recombinante, atenuada), primeira vacina contra dengue registrada no Brasil, teve seu registro concedido pela Anvisa em 28/12/2015.

GACVS Statement on Dengvaxia ® (CYD-TDV)

Global Vaccine Safety

Brazil is at high risk of future epidemics, says expert in emerging infectious diseases

To the Emerging Infectious Diseases program professor at Duke National University at Singapore Medical School, Mayaro and other viruses may emerge from the Amazon basin

Brazil records increase in number of human brucellosis cases due to vaccine accident

According to infectious diseases and human brucellosis expert, Dr. Marcos Vinícius da Silva, the vaccines used for animals, both cattle and goats, can develop the disease in humans

Beer increases amount of mosquito bites

Among the many factors, consumption of certain foods and drinks can influence the attraction of mosquitoes and other blood feeding insects

Sanitation investments in Brazil are very delayed to meet the current demand

Besides direct benefits over public well-being, sanitation services are also able to complement other important government priorities, as public health policies and poverty reduction

New medicine field could help handling endemic and emerging infectious diseases

According to Dr Montira Pongsiri, Planetary Health is a new insight on our planet’s health and could help preventing future threats

Lançamento do livro “Imagens, Micróbios e Espelhos”

Second autochthonous case of kala-azar is confirmed in Florianópolis

Expert acknowledges human visceral leishmaniasis urbanization trend